1、Li X, Liu Z, Cao J, Hong X, Wang J, Chen F, Wang C, Zou S, Li J#, Shen Z.. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.. Annals of Hematology,2012;Jun;91(6):837-45.
2、Li X, Shen W, Cao J, Wang J, Chen F, Wang C, Zou S, Shen B, Zhao R, Li J#, Shen Z.. Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases.. Annals of Hematology,2012;Nov;91(11):1721-9
3、Ai-Hua WANG, Lin WEI, Li CHEN,Shu-Qing ZHAO, Wei-Li WU, Zhi-Xiang SHEN, Jun-Min LI#. Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells.. Annals of Hematology,2011;Aug;90(8):917-31
4、Ai-Hua Wang, Yan-Yan Wang, Yu Yao, Zi-Zhen Xu, Li Zhou, Li Wang, Li Zhang, Yu Chen, Zhi-Xiang Shen,Jiong Hu, Jun-Min Li#. Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006. Journal of Experimental & Clinical Cancer Research,2010;Mar 3;29:20
5、Xia ZG, Xu ZZ, Zhao WL, Zhao SQ, Ding F, Chen Y, Chen QS, Zheng Y, Zhu Q, Hu JP, Shen ZX, Li JM#. he prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment.. Annals of Hematology,2010;Feb;89(2):171-7
|
